MedPath
TGA Approval

SALFLUMIX EASYHALER 500/50 fluticasone propionate/salmeterol (as xinafoate) 500ug/50ug Powder for inhalation Dry powder Inhaler (338158)

338158

SALFLUMIX EASYHALER 500/50 fluticasone propionate/salmeterol (as xinafoate) 500ug/50ug Powder for inhalation Dry powder Inhaler

Orion Pharma (AUS) Pty Limited

October 28, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/75b41edd49881f2fc16530f9a0084f9b.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/f03e90a0b67f070a05cff5f27c56c89f.pdf

Active Ingredients

fluticasone propionate

salmeterol xinafoate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SALFLUMIX EASYHALER 500/50 fluticasone propionate/salmeterol (as xinafoate) 500ug/50ug Powder for inhalation Dry powder Inhaler (338158) - TGA 批准文号 | MedPath